 |
| Mayo Clinic YouTube |
CANCER DIGEST – May 15, 2015 – In a first in class clinical trial, Mayo Clinic researchers have demonstrated a new approach to treating blood cancer using an engineered dose of the measles virus. Two patients in the early stage trial with multiple myeloma, a cancer of the plasma cells, were given doses of the virus and both have responded with reductions of cancer in the bone marrow. One patient, a 49-year-old woman, experienced complete remission of myeloma and has been clear of the disease for over six months. The findings appear in the journal Mayo Clinic Proceedings.
No comments:
Post a Comment